LPAR3 Antikörper (AA 101-200) (Biotin)
-
- Target Alle LPAR3 Antikörper anzeigen
- LPAR3 (Lysophosphatidic Acid Receptor 3 (LPAR3))
-
Bindungsspezifität
- AA 101-200
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LPAR3 Antikörper ist konjugiert mit Biotin
-
Applikation
- ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Maus
- Homologie
- Rat,Dog,Cow,Pig,Horse,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human EDG7/LPA3
- Isotyp
- IgG
- Top Product
- Discover our top product LPAR3 Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C for 12 months.
- Haltbarkeit
- 12 months
-
- Target
- LPAR3 (Lysophosphatidic Acid Receptor 3 (LPAR3))
- Andere Bezeichnung
- LPA3 (LPAR3 Produkte)
- Hintergrund
-
Synonyms: EDG7, GPCR, LPA3, Edg-7, LP-A3, HOFNH30, RP4-678I3, Lysophosphatidic acid receptor 3, LPA receptor 3, LPA-3, Lysophosphatidic acid receptor Edg-7, LPAR3
Background: Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. May play a role in the development of ovarian cancer. Seems to be coupled to the G(i)/G(o) and G(q) families of heteromeric G proteins.
- Gen-ID
- 23566
- UniProt
- Q9UBY5
- Pathways
- Regulation of Cell Size
-